MicroRNA-127 and MicroRNA-132 Expression in Patients with Methamphetamine Abuse in East Azerbaijan, Iran: A Case-Control Study
Open Access
- 29 July 2022
- journal article
- research article
- Published by Maad Rayan Publishing Company in Addiction & Health
- Vol. 14 (3) , 214-217
Abstract
Background: Addiction is a personal and social problem worldwide, and has physical and psychological effects on consumers’ health. Recently, miRNAs have been described as noninvasive biomarkers. Currently, methamphetamine abuse (MA) is mainly diagnosed by chromatography. This study aimed to investigate the expression and diagnostic value of miR-127 and miR-132 in blood samples of patients with MA and non-user healthy controls. Methods: A total of 60 patients with MA (case group) and 60 non-user healthy individuals (control group) were selected from Tabriz, East Azerbaijan, Iran. Peripheral blood was obtained and total RNA was extracted. Then, cDNA synthesis was performed and miR-127 and miR-132 expression was evaluated using real time polymerase chain reaction (PCR) method. Findings: The results of this study demonstrated that miR-127 was significantly lower (0.042-fold change) in patients with MA than in the control group (P<0.05). However, miR-132 was significantly higher (7.1-fold change) in patients with MA than in the control group (P<0.05). Conclusion: In general, expression of miR-127 and miR-132 may alter in patients with MA. Further studies are needed to identify underlying molecular mechanisms in patients with MA.Keywords
This publication has 21 references indexed in Scilit:
- The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settingsContemporary Clinical Trials, 2016
- Decreased Expression of Plasma MicroRNA in Patients with Methamphetamine (MA) Use DisorderJournal of Neuroimmune Pharmacology, 2016
- Prolonged Induction of miR-212/132 and REST Expression in Rat Striatum Following Cocaine Self-AdministrationMolecular Neurobiology, 2016
- Targeting MicroRNA Function in Respiratory Diseases: Mini-ReviewFrontiers in Physiology, 2016
- Evaluation of single nucleotide polymorphisms in the miR-183–96–182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs)European Neuropsychopharmacology, 2013
- MicroRNAs as biomarkers for CNS diseaseFrontiers in Molecular Neuroscience, 2013
- MicroRNAs and Drug AddictionFrontiers in Genetics, 2013
- Circulating microRNAs: Association with disease and potential use as biomarkersCritical Reviews in Oncology/Hematology, 2011
- Bioanalytical procedures for determination of drugs of abuse in bloodAnalytical and Bioanalytical Chemistry, 2007
- Drugs of Abuse and the BrainProceedings of the Association of American Physicians, 1999